Results 221 to 230 of about 164,343 (265)

Mixed Invasive Adenoid Cystic and Lobular Carcinoma of the Breast: A Case Report of a Rare Hybrid Tumor. [PDF]

Cureus
Babker MS, Chavarria H.
europepmc   +1 more source

Nanoparticle‐Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple‐Negative Breast Cancer by Modulating RAB7A Ubiquitination‐Associated Stability and Autophagy

Advanced Science, EarlyView.
TIPE1m NPs nanoparticles restore TIPE1 expression, promote RAB7A ubiquitination and degradation, suppress autophagic flux, and resensitize paclitaxel‐resistant triple‐negative breast cancer to therapy. ABSTRACT Acquired paclitaxel (PTX) resistance remains a major obstacle in triple‐negative breast cancer (TNBC) treatment.
Wei Hu, Qishuai Chen, Yan Ma, Yang Liu, Xianing Dong, Wenjuan Wei, Jianxin Du, Shusheng Qiu, Maojin Tian, Peiqing Zhao   +9 more
wiley   +1 more source

SPDEF downregulation promotes tumor aggressiveness and poor prognosis in triple-negative breast cancer. [PDF]

Transl Cancer Res
Wei C, Liu Q, Wang H, Liu X.
europepmc   +1 more source

The Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products. [PDF]

Int J Breast Cancer
Jaman MS, Maniruzzaman M, Bhuiyan MRH, Haque MS.   +3 more
europepmc   +1 more source

PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. [PDF]

Medicine (Baltimore)
Zhang J, Pei J, Hao G, Meng Y, Li F, Xu H, Liu H.   +6 more
europepmc   +1 more source

A Case of Neoadjuvant Chemotherapy for Locally Advanced Inflammatory Breast Cancer With Low-Level ER Expression. [PDF]

Case Rep Med
Qin Q, Jia W.
europepmc   +1 more source

Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk.

JAMA Netw Open
Sun Y, Simmons T, Li JL, Jamal A, Manirakiza AVC, Pruss D, Ratzel S, Olopade OI, Gutin A, Hughes E, Huo D.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Investigation of the synergic effect of mocetinostat and capecitabine in a triple-negative breast neoplasms mouse model

Journal of Investigative Medicine
Combined administration of two or more drugs is emerging as a new strategy in triple-negative breast neoplasms. This is the first study to investigate the combination of the histone deacetylase inhibitor mocetinostat and the antimetabolite drug capecitabine in triple-negative mammary neoplasms in a preclinical mouse model.
Onur Eroglu, Hacer Kaya Cakir
exaly   +5 more sources